Briefly: Immune therapies such as IVIG are increaingly used in some GI motility patients.

History: Adapted from the Neuro-muscular literature, use of immune therapies is growing, as of 2024.

Projects: Several centers, incluing U of L, have ongoint series.

Original Publications: to follow

Conclusions: Immunotehrapy is important and selection criteria for who will benefit is comig along.